Study guide
21.3 Biostatistics, Study Design & Critical Appraisal
Integrated National Board Dental Examination INBDE
Track your progress as you read
Finished sections get a check mark.
1 Chapter 1: INBDE Exam Structure & Test Specifications
1.1 INBDE Format, Administration, Scoring & Retesting 1.2 The Domain of Dentistry: Test Specifications, Item Formats, Patient Boxes & Dental Charts
2 Chapter 2: Foundation Knowledge — Anatomic Sciences & Development
2.1 Gross & Head/Neck Anatomy and Histology 2.2 Oral Embryology, Tooth Development & Eruption 2.3 Genetic, Congenital & Developmental Conditions
3 Chapter 3: Foundation Knowledge — Biochemistry, Physiology & Physical Sciences
3.1 Biochemistry and Systemic Physiology 3.2 Physics & Chemistry of Oral Biology: pH, Diffusion & Demineralization
4 Chapter 4: Foundation Knowledge — Pathology, Microbiology & Immunology
4.1 General & Systemic Pathology 4.2 Microbiology, Immunology, and Infection Pathogenesis
5 Chapter 5: Foundation Knowledge — Pharmacology
5.1 Dental Pharmacology, Local Anesthetics, and Analgesics 5.2 Systemic Medications and Drug Interactions in Dentistry
6 Chapter 6: Foundation Knowledge — Dental Anatomy, Occlusion & Materials
6.1 Tooth Morphology, Anatomy, and Occlusion Biomechanics 6.2 Dental Materials Science, Biomaterials, and Impression Systems
7 Chapter 7: Patient Evaluation & Data Gathering
7.1 Chief Complaint, History Taking & Information from Diverse Sources 7.2 Comprehensive Patient History, Examination, and Medical Risk Assessment 7.3 Vital Signs, ASA Physical Status & Medical Risk Stratification 7.4 Normal Findings vs Significant Deviations Requiring Management
8 Chapter 8: Diagnostic Imaging
8.1 Dental Radiology Physics, Safety, and Imaging Interpretation 8.2 Intraoral Radiographic Technique, Errors & Quality Assurance 8.3 Radiographic Interpretation of Caries, Periapical & Bone Lesions 8.4 Panoramic, CBCT & Selection Criteria for Advanced Imaging
9 Chapter 9: Diagnostic Reasoning & Systemic Assessment
9.1 Diagnostic Testing, Laboratory Values, and Medical Complexities 9.2 Predictive Diagnostic Reasoning & Selecting the Right Diagnostic Test 9.3 Oral–Systemic Interrelationships 9.4 Differential Diagnosis of Orofacial Pain
10 Chapter 10: Oral Pathology & Mucosal Disease
10.1 Benign and Malignant Oral Pathology and Biopsy Protocols 10.2 Managing Oral Mucosal and Osseous Diseases
11 Chapter 11: Treatment Planning, Prognosis & Communication
11.1 Interdisciplinary Treatment Planning Sequencing and Prognosis 11.2 Prognosis Determination & Presenting Treatment Alternatives 11.3 Informed Consent, Refusal & Patient Education 11.4 Patient Attributes, Culture, Social Background & Care Across the Lifespan 11.5 Psychological, Social & Behavioral Principles in Patient Communication 11.6 Evaluating the Outcomes of Comprehensive Dental Care
12 Chapter 12: Medical & Dental Emergencies
12.1 Dental and Medical Emergencies in the Dental Office 12.2 Recognizing and Triaging Dental Emergencies
13 Chapter 13: Caries, Operative & Esthetic Dentistry
13.1 Caries Risk Assessment, Prevention, and Operative Dentistry 13.2 Adhesive Dentistry, Composite/Amalgam Restorations, and Esthetics 13.3 Managing the Esthetic Needs of Patients
14 Chapter 14: Endodontics
14.1 Pulpal Biology, Endodontic Diagnosis, and Emergency Treatment 14.2 Endodontic Therapy, Root Canal Instrumentation, Obturation, and Surgery
15 Chapter 15: Periodontics & Implantology
15.1 Periodontal Pathogenesis, Etiology, and Disease Classification 15.2 Non-Surgical Periodontal Therapy and Maintenance Protocols 15.3 Surgical Periodontics, Mucogingival Procedures, and Regenerative Care 15.4 Dental Implants: Planning, Surgical Placement, and Restorative Options
16 Chapter 16: Prosthodontics & Laboratory Communication
16.1 Fixed Prosthodontics: Crown/Bridge Preparation, Design, and Cementation 16.2 Removable Complete Dentures: Impression, Occlusion, and Delivery 16.3 Removable Partial Dentures: Components, Design, and Frameworks 16.4 Communicating Case Design to the Dental Laboratory
17 Chapter 17: Pain Control, Anesthesia & Oral Surgery
17.1 Local Anesthetic Techniques, Complications, and Nitrous Oxide Sedation 17.2 Dentoalveolar Surgery, Tooth Extraction, and Surgical Complications 17.3 Maxillofacial Trauma, Odontogenic Infections, and Complex Surgery
18 Chapter 18: Occlusion, TMD & Orthodontics
18.1 Craniofacial Growth, Development, and Orthodontic Diagnosis/Intervention 18.2 Developmental & Acquired Occlusal Problems 18.3 Temporomandibular Disorders: Diagnosis and Management
19 Chapter 19: Pediatric, Special Care & Vulnerable Patients
19.1 Pediatric Dental Care, Behavior Guidance, and Preventive Services 19.2 Pediatric Restorative Dentistry, Pulpal Therapy, and Dental Trauma 19.3 Special Care Dentistry: Geriatric, Special Needs, and Medically Compromised Patients 19.4 Recognizing, Managing & Reporting Patient Abuse and Neglect 19.5 Recognizing and Managing Substance Use Disorders
20 Chapter 20: Practice Management, Safety Systems & Informatics
20.1 Infection Control Protocols, Sterilization, and OSHA Compliance 20.2 Radiation Safety Guidelines, Dosimetry, and ALARA Principles 20.3 Practice Business Operations, OSHA & Regulatory Compliance 20.4 Catastrophe Preparedness & Practice Continuity Planning 20.5 Managing, Coordinating & Supervising Allied Dental Personnel 20.6 Quality Assurance, Assessment and Improvement 20.7 Dental Informatics, Electronic Records & Emerging Technology 20.8 Scope of Competence, Referral & Professional Self-Assessment
21 Chapter 21: Ethics, Jurisprudence, Evidence & Public Health
21.1 ADA Ethics Code, Jurisprudence, HIPAA, and Professional Conduct 21.2 Evidence-Based Dentistry, Clinical Epidemiology, and Dental Public Health 21.3 Biostatistics, Study Design & Critical Appraisal 21.4 Community Collaboration & Systems of Oral Health Care Delivery 21.5 Emerging Trends and Social/Economic Forces in Oral Health Care 21.6 Prevention, Intervention & Patient Education Strategies
21.3 Biostatistics, Study Design & Critical Appraisal
Key Takeaways Explain This Topic AI
The randomized controlled trial is the strongest single study design for establishing that an intervention causes an effect, and systematic reviews of such trials sit above it in the evidence hierarchy
A case-control study yields an odds ratio and a cohort study yields relative risk, which is why odds ratios appear in studies of rare outcomes
A p-value below 0.05 indicates statistical significance but says nothing about clinical importance or effect size
A 95 percent confidence interval for a relative risk or odds ratio that includes 1.0 indicates a non-significant result
Number needed to treat is the reciprocal of the absolute risk reduction, and relative risk reduction alone systematically overstates benefit
Last updated: August 2026
Biostatistics, Study Design & Critical Appraisal
Why this matters on the INBDE: FK10 carries 10% of examination items — roughly 50 items — and it is the area candidates most often skip entirely. The content is finite and highly learnable, which makes it one of the best returns on study time available.
The Evidence Hierarchy
Level Design Strength and use
1 Systematic review / meta-analysis of randomized controlled trials Highest level for therapy questions; a meta-analysis statistically pools results
2 Randomized controlled trial (RCT) The only design that reliably establishes causation , because randomization balances known and unknown confounders
3 Cohort study Follows exposed and unexposed groups forward; yields relative risk and incidence
4 Case-control study Starts with the outcome and looks backward at exposure; yields an odds ratio ; efficient for rare outcomes and long latency
- 5 Cross-sectional study A snapshot at one point in time; yields prevalence ; cannot establish temporality
- 6 Case series / case report Descriptive; hypothesis-generating only
- 7 Expert opinion, bench research, animal studies Lowest for clinical decisions
A critical distinction: the hierarchy applies to therapy questions. For a prognosis question the best design is a cohort study; for diagnostic accuracy it is a cross-sectional study comparing the test against a reference standard in an appropriate spectrum of patients; for harm from a rare event it is often a case-control study, because an RCT would be unethical or impossibly large.
Features that make a trial trustworthy
Randomization — allocation by chance, balancing confounders.
Allocation concealment — the person enrolling cannot know the next assignment.
Blinding — single (patient), double (patient and clinician/assessor), or triple (including the analyst). Placebo control where feasible.
Intention-to-treat analysis — participants are analyzed in the group to which they were randomized, regardless of what they actually received. This preserves randomization and is the conservative analysis; per-protocol analysis exaggerates benefit.
Adequate power and a pre-specified primary outcome.
Accounting for all participants — high or differential loss to follow-up undermines the result.
Descriptive Statistics
- Measure Definition When to prefer it
- Mean Arithmetic average Symmetric, normally distributed data
- Median Middle value Skewed data or outliers — income, waiting times, pocket depths in a diseased population
- Mode Most frequent value Categorical data
- Range Maximum minus minimum Crude spread; sensitive to outliers
- Standard deviation Average deviation from the mean Spread of the data
Standard error of the mean SD divided by the square root of n Precision of the estimate ; always smaller than SD
In a normal distribution , approximately 68% of values fall within one standard deviation of the mean, 95% within two, and 99.7% within three. In a right-skewed distribution the mean exceeds the median ; in a left-skewed distribution the median exceeds the mean.
Levels of measurement
- Scale Definition Dental example
- Nominal Categories without order Tooth type, sex, material used
- Ordinal Ordered categories with unequal intervals Mobility Class I/II/III, plaque index, pain 0–10
- Interval Equal intervals, arbitrary zero Temperature in Celsius
- Ratio Equal intervals, true zero Probing depth in millimeters, age, DMFT count
- Inferential Statistics
- Hypothesis testing
The null hypothesis states there is no difference. Statistics test whether the observed data are compatible with it.
The p-value is the probability of obtaining a result at least as extreme as the observed one if the null hypothesis were true . A p-value below the conventional alpha of 0.05 is called statistically significant.
A p-value is not the probability that the null hypothesis is true, and it says nothing about effect size or clinical importance. With a large enough sample, a clinically trivial difference becomes statistically significant.
Error Definition Controlled by
Type I (alpha) Rejecting a true null — a false positive finding Setting alpha, usually 0.05; correcting for multiple comparisons
Type II (beta) Failing to reject a false null — a false negative Power = 1 − beta, conventionally 0.80 or higher; achieved chiefly through sample size
Confidence intervals
A 95% confidence interval is the range that would contain the true population value in 95% of repeated samples. It is more informative than a p-value because it conveys both significance and precision.
For a ratio measure (relative risk, odds ratio, hazard ratio), an interval that includes 1.0 is not significant .
For a difference measure (mean difference, risk difference), an interval that includes 0 is not significant .
A wide interval signals imprecision, usually from a small sample.
Common tests
- Comparison Test
- Two independent group means, continuous data Independent t-test
- Paired measurements (before/after in the same subjects) Paired t-test
- Three or more group means ANOVA
- Categorical proportions Chi-square (Fisher exact test for small expected counts)
- Relationship between two continuous variables Correlation (r), then regression for prediction
- Time to an event Kaplan-Meier survival analysis, log-rank test, Cox regression
- Non-normal or ordinal data Non-parametric equivalents — Mann-Whitney U, Wilcoxon signed-rank, Kruskal-Wallis
Correlation coefficients run from −1 to +1. Correlation does not establish causation , and the coefficient describes only a linear relationship.
Measures of Effect
- Measure Formula in words Note
- Incidence New cases in a population at risk over a period Requires follow-up
- Prevalence Existing cases at a point in time From cross-sectional data
- Relative risk (RR) Risk in exposed divided by risk in unexposed Cohort studies and RCTs
Odds ratio (OR) Odds of exposure in cases divided by odds in controls Case-control studies ; approximates RR when the outcome is rare
- Absolute risk reduction (ARR) Control event rate minus treated event rate The clinically meaningful magnitude
- Relative risk reduction (RRR) ARR divided by control event rate Systematically sounds larger than it is
Number needed to treat (NNT) 1 divided by the ARR Number of patients treated to prevent one event; smaller is better
The classic appraisal trap: a paper reports a "50% reduction in caries." If the control incidence was 2% and the treated incidence 1%, the relative reduction is 50% but the absolute reduction is 1 percentage point, and the NNT is 100 . Always ask for the absolute numbers.
Diagnostic Test Measures
- Measure Definition
- Sensitivity True positives divided by all who have the disease — SnNout
- Specificity True negatives divided by all without the disease — SpPin
- Positive predictive value True positives divided by all who test positive — falls as prevalence falls
- Negative predictive value True negatives divided by all who test negative — rises as prevalence falls
- Reliability Reproducibility — kappa for categorical agreement, intraclass correlation for continuous
- Validity Whether the test measures what it claims
Kappa corrects agreement for chance: values above roughly 0.80 represent excellent agreement, 0.60–0.80 substantial, 0.40–0.60 moderate, and below 0.40 poor.
Bias and Confounding
Problem Description Remedy
Selection bias The sample is not representative of the target population Random sampling, consecutive enrollment, clear eligibility criteria
Information / measurement bias Systematic error in measuring exposure or outcome Calibration, standardized instruments, blinding
- Recall bias Cases remember exposures differently from controls Prospective design, records-based exposure
- Observer bias The assessor's expectation influences measurement Blinded outcome assessment
- Attrition bias Differential loss to follow-up between groups Intention-to-treat, sensitivity analysis
- Publication bias Positive studies are more likely to be published Trial registries, funnel plots
Confounding A third variable is associated with both exposure and outcome Randomization (best), restriction, matching, stratification, multivariable adjustment
The classic dental confounder is smoking , which is associated with both periodontal disease and many exposures of interest. A study reporting an association between periodontitis and an outcome that does not adjust for smoking has not answered the question.
Research Ethics
Human-subjects research requires Institutional Review Board (IRB) approval, informed consent for research that is distinct from clinical consent, protection of vulnerable populations (children, prisoners, cognitively impaired adults), an independent data safety monitoring board for higher-risk trials, and disclosure of conflicts of interest and funding sources . Equipoise — genuine uncertainty about which arm is superior — is the ethical precondition for randomizing patients at all.